Keppra Tablets – Levetiracetam, 60 Tablets

  • Treatment of epilepsy in adults and children
  • Treatment of seizures and epilepsy in dogs and cats when prescribed by a vet


SKU: 27497290. Category:
  • Treatment of epilepsy in adults and children
  • Treatment of seizures and epilepsy in dogs and cats when prescribed by a vet

Keppra Tablets – Levetiracetam, 60 Tablets

If you suffer from seizures, you may be interested in Keppra Tablets. The active ingredient in Keppra is Levetiracetam, which is an antiepileptic medicine used to treat seizures in epilepsy. This medicine works by binding to a particular protein in the brain, which helps to reduce the occurrence of seizures.

Keppra is available in tablet and oral solution form. The recommended starting dose for Keppra is 1000 mg/day given as two divided doses. The maintenance dose is 2000-3000 mg/day given as two divided doses.

Keppra tablets are available in 4 strenghts: 250mg, 500mg, 750mg and 1000mg

keppra tablets can be used in dogs and cats when prescribed by a vet

Keppra Tablets Reviews

After using Keppra Tablets, it’s helpful to let others know about your experience. Reviews of an item help other users know that medicines received have helped the condition it is claimed for, how well the treatment worked or any issues to be aware of. We invite our users to leave a review of both their treatment and of the service provided. Click on the reviews tab to see if there has been feedback on this item.

What is the price of  Keppra Tablets?

The price of  Keppra Tablets starts from £39.90

Where can you buy Keppra Tablets?

You can buy Keppra Tablets at Dock Pharmacy Essex UK, UK Online Pharmacy.

Can you buy Keppra Tablets Over the counter?

Keppra Tablets is not available to buy over the counter. You need a prescription to buy Keppra Tablets






1000mg, 250mg, 500mg, 750mg

How To Use

How to take Keppra

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Take the number of tablets following your doctor’s instructions. Keppra must be taken twice a day, once in the morning and once in the evening, at about the same time each day

Adjunctive Therapy and monotherapy (from 16 years of age)

  • Adults (≥18 years) and adolescents (12 to 17 years) weighing 50 kg or more: Recommended dose: between 1,000 mg and 3,000 mg each day. When you will first start taking Keppra, your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest daily dose. Example: if your daily dose is intended to be 1,000 mg, your reduced starting dose is 1 tablet of 250 mg in the morning and 1 tablet of 250 mg in the evening, and the dose will be gradually incremented to reach 1,000 mg daily after 2 weeks.
  • Adolescents (12 to 17 years) weighing 50 kg or less: Your doctor will prescribe the most appropriate pharmaceutical form of Keppra according to weight and dose.
  • Dose in infants (1 month to 23 months) and children (2 to 11 years) weighing less than 50 kg: Your doctor will prescribe the most appropriate pharmaceutical form of Keppra according to the age, weight and dose.

Method of administration

Swallow Keppra tablets with a sufficient quantity of liquid (e.g. a glass of water).

You may take Keppra with or without food.

After oral administration the bitter taste of levetiracetam may be experienced.

Duration of treatment

  • Keppra is used as a chronic treatment. You should continue Keppra treatment for as long as your doctor has told you.
  • Do not stop your treatment without your doctor’s advice as this could increase your seizures.

Delivery Options

Delivery options

All deliveries are subject to the availability of the product and product sale conditions been met.

Order & Collect
Free next-day collection from In-Store

UK Delivery

Standard Delivery within the UK £3.50 Delivery time 3-4 days
First Class Delivery within the UK £5.90 Delivery time 1-2 days
Priority Delivery within the UK £7.10. Next day delivery by 1pm. Order must be placed by 1pm. Priority delivery is only available Monday to Thursday.

Europe Delivery

Standard Delivery within EEC from £12.50 Delivery time up to 5 days depending on the local delivery service within your country.
Expedited Delivery within EEC £39.50 Delivery time 2 days. Delivery by DHL, UPS or TNT.

Rest of the World

Standard Delivery Rest of the World from £16.10 Delivery Time 10 – 15 Days
Expedited Delivery Rest of the World £55.09 Delivery 5 days. Delivery service by DHL, TNT or UPS

For more information see our Shipping Policy or view our Return policy.

Product Details

What you need to know before you take Keppra

Do not take Keppra • If you are allergic to levetiracetam, pyrrolidone derivatives or any of the other ingredients of this medicine (listed in Section 6). 2 Warnings and precautions Talk to your doctor before taking Keppra • If you suffer from kidney problems, follow your doctor’s instructions. He/she may decide if your dose should be adjusted. • If you notice any slowdown in the growth or unexpected puberty development of your child, please contact your doctor. • A small number of people being treated with anti-epileptics such as Keppra have had thoughts of harming or killing themselves. If you have any symptoms of depression and/or suicidal ideation, please contact your doctor. • If you have a family or medical history of irregular heart rhythm (visible on an electrocardiogram), or if you have a disease and/or take a treatment that make(s) you prone to heartbeat irregularities or salt imbalances. Tell your doctor or pharmacist if any of the following side effects gets serious or last longer than a few days: • Abnormal thoughts, feeling irritable or reacting more aggressively than usually, or if you or your family and friends notice important changes in mood or behaviour. • Aggravation of epilepsy Your seizures may rarely become worse or happen more often, mainly during the first month after the start of the treatment or increase of the dose. If you experience any of these new symptoms while taking Keppra, see a doctor as soon as possible. Children and adolescents • Keppra is not indicated in children and adolescents below 16 years on its own (monotherapy). Other medicines and Keppra Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Do not take macrogol (a drug used as laxative) for one hour before and one hour after taking levetiracetam as this may results in a loss of its effect. Pregnancy and breast-feeding If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Levetiracetam can be used during pregnancy, only if after careful assessment it is considered necessary by your doctor. You should not stop your treatment without discussing this with your doctor. A risk of birth defects for your unborn child cannot be completely excluded. Breast-feeding is not recommended during treatment. Driving and using machines Keppra may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy. This is more likely at the beginning of treatment or after an increase in the dose. You should not drive or use machines until it is established that your ability to perform such activities is not affected. Keppra 750 mg tablets contain Sunset Yellow FCF (E110). Sunset Yellow FCF (E110) colouring agent may cause allergic reactions.

Side Effects

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Tell your doctor immediately, or go to your nearest emergency department, if you experience: • weakness, feel light-headed or dizzy or have difficulty breathing, as these may be signs of a serious allergic (anaphylactic) reaction • swelling of the face, lips, tongue and throat (Quincke’s oedema) • flu-like symptoms and a rash on the face followed by an extended rash with a high temperature, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes (Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]) • symptoms such as low urine volume, tiredness, nausea, vomiting, confusion and swelling in the legs, ankles or feet, as this may be a sign of sudden decrease of kidney function • a skin rash which may form blisters and look like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme) • a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome) • a more severe form of rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis) • signs of serious mental changes or if someone around you notices signs of confusion, somnolence (sleepiness), amnesia (loss of memory), memory impairment (forgetfulness), abnormal behaviour or other neurological signs including involuntary or uncontrolled movements. These could be symptoms of an encephalopathy. The most frequently reported side effects are nasopharyngitis, somnolence (sleepiness), headache, fatigue and dizziness. At the beginning of the treatment or at dose increase side effects like sleepiness, tiredness and dizziness may be more common. These effects should however decrease over time. Very common: may affect more than 1 in 10 people • nasopharyngitis; • somnolence (sleepiness), headache. Common: may affect up to 1 in 10 people • anorexia (loss of appetite); • depression, hostility or aggression, anxiety, insomnia, nervousness or irritability; • convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy (lack of energy and enthusiasm), tremor (involuntary trembling); • vertigo (sensation of rotation); • cough; • abdominal pain, diarrhoea, dyspepsia (indigestion), vomiting, nausea; • rash; • asthenia/fatigue (tiredness). Uncommon: may affect up to 1 in 100 people • decreased number of blood platelets, decreased number of white blood cells; • weight decrease, weight increase; • suicide attempt and suicidal ideation, mental disorder, abnormal behaviour, hallucination, anger, confusion, panic attack, emotional instability/mood swings, agitation; • amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration); • diplopia (double vision), vision blurred; • elevated/abnormal values in a liver function test; • hair loss, eczema, pruritus; 5 • muscle weakness, myalgia (muscle pain); • injury. Rare: may affect up to 1 in 1,000 people • infection; • decreased number of all blood cell types; • severe allergic reactions (DRESS, anaphylactic reaction [severe and important allergic reaction], Quincke’s oedema [swelling of the face, lips, tongue and throat]); • decreased blood sodium concentration; • suicide, personality disorders (behavioural problems), thinking abnormal (slow thinking, unable to concentrate); • delirium; • encephalopathy (see sub-section “Tell your doctor immediately” for a detailed description of symptoms); • seizures may become worse or happen more often; • uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity); • change of the heart rhythm (Electrocardiogram); • pancreatitis; • liver failure, hepatitis; • sudden decrease in kidney function; • skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens– Johnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis); • rhabdomyolysis (breakdown of muscle tissue) and associated blood creatine phosphokinase increase. Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients. • limp or difficulty walking. Evidence also suggests a possible predisposition of the Japanese population to neuroleptic malignant syndrome (NMS). Reporting of side effects If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.


What Keppra contains
The active substance is called levetiracetam.
One tablet of Keppra 250 mg contains 250 mg of levetiracetam.
One tablet of Keppra 500 mg contains 500 mg of levetiracetam.
One tablet of Keppra 750 mg contains 750 mg of levetiracetam.
One tablet of Keppra 1,000 mg contains 1,000 mg of levetiracetam.
The other ingredients are:
Tablet core: croscarmellose sodium, macrogol 6000, silica colloidal anhydrous, magnesium stearate.
Film-coating: Polyvinyl alcohol-part. hydrolyzed, titanium dioxide (E171), macrogol 3350, talc, colourants*.

How to Store

How to store Keppra

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the carton box and blister after EXP. The expiry date refers to the last day of the month. This medicine does not require any special storage conditions. 6 Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Patient Information leaflet

Click here  for the Patient Information Leaflet for Keppra

Please read before using the product


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Questions and answers of the customers

There are no questions yet, be the first to ask something for this product.

You Might Also Like

Other Products From This Seller